Genesco (NYSE: GCO) awards director 3,905 restricted stock shares

Q: What type of security did Genesco (GCO) grant to John F. Lambros?

John F. Lambros received restricted shares of Genesco common stock . These were granted under the Fourth Amended and Restated 2020 Equity Incentive Plan as a stock-based compensation award, rather than acquired through a market purchase.

Q: What does the transaction code "A" mean in Genesco (GCO) director Lambros’s Form 4?

The Form 4 uses transaction code “A” , indicating a grant, award, or other acquisition of securities. In this case, it refers to the grant of 3,905 restricted common shares to director John F. Lambros as equity compensation.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Lambros John F reported acquisition or exercise transactions in this Form 4 filing.

Genesco Inc. director John F. Lambros received a grant of 3,905 shares of restricted common stock on July 24, 2026, at no cash cost, as equity compensation under the company’s Fourth Amended and Restated 2020 Equity Incentive Plan.

After this award, Lambros directly owns 23,705 Genesco common shares. The transaction is reported as not made pursuant to a Rule 10b5-1 trading plan.

Insider Trade Summary

Net Buyer: 3,905 shares

Net Buy 1 txn

Insider Lambros John F

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock ^F1	3,905	$0.00	$0.00

Holdings After Transaction: Common Stock — 23,705 shares (Direct)

Footnotes (1)

F1. Grant of restricted stock under the Fourth Amended and Restated 2020 Equity Incentive Plan.

Key Figures

Restricted stock granted: 3,905 shares Shares owned after transaction: 23,705 shares Transaction price per share: 0.0000 +1 more

4 metrics

Restricted stock granted 3,905 shares Grant to director John F. Lambros on July 24, 2026

Shares owned after transaction 23,705 shares Direct ownership reported for John F. Lambros after the grant

Transaction price per share 0.0000 Reported acquisition price for the restricted stock grant

Number of transactions reported 1 Single Form 4 transaction for restricted stock grant

Key Terms

restricted stock, Fourth Amended and Restated 2020 Equity Incentive Plan, Rule 10b5-1 trading plans

3 terms

restricted stock financial

"Grant of restricted stock under the Fourth Amended and Restated 2020 Equity Incentive Plan."

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Fourth Amended and Restated 2020 Equity Incentive Plan financial

"Grant of restricted stock under the Fourth Amended and Restated 2020 Equity Incentive Plan."

Rule 10b5-1 trading plans regulatory

"Footnotes may reference Rule 10b5-1 trading plans or pre-arranged trading arrangements"

Rule 10b5-1 trading plans are written, pre-arranged instructions that allow company insiders (such as executives or directors) to automatically buy or sell their company's stock at specified times or under set conditions, like a standing instruction or automated thermostat for trades. They matter to investors because these plans provide a legal defense against insider‑trading accusations and create predictable insider trading patterns that can help signal whether sales are routine portfolio management or potentially meaningful to the company’s outlook.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/24/2026 - 04:03 PM Accepted by SEC EDGAR 07/24/2026 - 04:02 PM

FAQ

What insider transaction did Genesco (GCO) report for John F. Lambros?

John F. Lambros, a director of Genesco, received a grant of 3,905 shares of restricted common stock on July 24, 2026. The shares were awarded at no cash cost as equity compensation under Genesco’s Fourth Amended and Restated 2020 Equity Incentive Plan.

How many Genesco (GCO) shares does John F. Lambros hold after this Form 4?

Following the reported grant, John F. Lambros directly owns 23,705 shares of Genesco common stock. This total reflects the addition of 3,905 restricted shares granted under the company’s Fourth Amended and Restated 2020 Equity Incentive Plan.

Was the Genesco (GCO) Lambros stock grant made under a Rule 10b5-1 plan?

The transaction is reported as not made pursuant to a Rule 10b5-1 trading plan. It represents an equity compensation grant rather than a pre-arranged trading plan purchase or sale in the open market.

What type of security did Genesco (GCO) grant to John F. Lambros?

John F. Lambros received restricted shares of Genesco common stock. These were granted under the Fourth Amended and Restated 2020 Equity Incentive Plan as a stock-based compensation award, rather than acquired through a market purchase.

What does the transaction code "A" mean in Genesco (GCO) director Lambros’s Form 4?

The Form 4 uses transaction code “A”, indicating a grant, award, or other acquisition of securities. In this case, it refers to the grant of 3,905 restricted common shares to director John F. Lambros as equity compensation.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lambros John F

(Last)

(First)

(Middle)

C/O GENESCO INC.

535 MARRIOTT DRIVE

(Street)

NASHVILLE

TENNESSEE

37214

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GENESCO INC [ GCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	07/24/2026		A		3,905⁽¹⁾	A	$0.00	23,705	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Grant of restricted stock under the Fourth Amended and Restated 2020 Equity Incentive Plan.

	Scott E. Becker, Attorney-in-Fact	07/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR